CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-12 | Sheena Jonathan Director | Sale 10b5-1 | −307 | $157.88 | $48K | 39,572 |
| 2025-05-12 | Sheena Jonathan Director | Sale 10b5-1 | −690 | $159.06 | $110K | 38,882 |
| 2025-05-12 | Sheena Jonathan Director | Sale 10b5-1 | −100 | $159.77 | $16K | 38,782 |
| 2025-05-12 | Sheena Jonathan Director | Sale 10b5-1 | −409 | $157.08 | $64K | 39,873 |
| 2025-05-12 | Sheena Jonathan Director | Sale 10b5-1 | −383 | $158.01 | $61K | 39,490 |
| 2025-05-12 | Sheena Jonathan Director | Sale 10b5-1 | −708 | $159.01 | $113K | 38,782 |
| 2025-05-09 | Sheena Jonathan Director | Sale 10b5-1 | −392 | $153.95 | $60K | 254,522 |
| 2025-05-09 | Sheena Jonathan Director | Sale 10b5-1 | −240 | $155.50 | $37K | 254,282 |
| 2025-05-09 | Sheena Jonathan Director | Sale 10b5-1 | −107 | $158.02 | $17K | 254,175 |
| 2025-05-09 | Sheena Jonathan Director | Sale 10b5-1 | −600 | $159.77 | $96K | 253,575 |
| 2025-05-09 | Sheena Jonathan Director | Sale 10b5-1 | −1,231 | $162.31 | $200K | 252,344 |
| 2025-05-09 | Sheena Jonathan Director | Sale 10b5-1 | −400 | $163.07 | $65K | 251,944 |
| 2025-05-09 | Sheena Jonathan Director | Sale 10b5-1 | −100 | $164.03 | $16K | 251,844 |
| 2025-05-01 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −2,009 | $148.25 | $298K | 190,153 |
| 2025-05-01 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −2,015 | $149.94 | $302K | 188,138 |
| 2025-05-01 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −2,186 | $151.26 | $331K | 185,952 |
| 2025-05-01 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −770 | $152.04 | $117K | 185,182 |
| 2025-05-01 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −853 | $148.25 | $126K | 138,352 |
| 2025-05-01 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −908 | $149.99 | $136K | 137,444 |
| 2025-05-01 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −908 | $151.30 | $137K | 136,536 |
Page 46 of 55 · 1,093 trades